Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dactinomycin 0.5mg;   - powder for injection - 0.5 mg - active: dactinomycin 0.5mg   excipient: mannitol

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - propantheline bromide 15mg;  ; propantheline bromide 15mg - tablet - 15 mg - active: propantheline bromide 15mg   excipient: calcium carbonate carnauba wax castor oil cosmetic red oxide no 6205 cosmetic red ochre no 1624 lactose monohydrate light liquid paraffin magnesium carbonate magnesium stearate maize starch purified talc saccharin sodium sucrose titanium dioxide yellow beeswax active: propantheline bromide 15mg excipient: lactose monohydrate magnesium stearate maize starch opadry orange 85g63218 purified talc - pro-banthine is indicated as an adjunctive therapy in the treatment of peptic ulcer (gastric and duodenal) and for the relief of the symptoms of gastritis. pro-banthine is also indicated for the symptomatic treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis, acute enterocolitis, nervous diarrhoea and functional gastrointestinal disorders). other indications include renal colic, hyperhidrosis, as adjunctive therapy in ulcerative colitis, diverticulitis, cholecystitis and pancreatitis and for certain gastrointestinal diagnostic procedures.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sevelamer hydrochloride 800mg;   - film coated tablet - 800 mg - active: sevelamer hydrochloride 800mg   excipient: colloidal silicon dioxide purified water stearic acid

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - plerixafor 20 mg/ml - solution for injection - 24 mg/1.2 ml - active: plerixafor 20 mg/ml excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - mozobil is indicated in combination with granulocyte-colony stimulating factor (g-csf) to mobilise haematopoietic stem cells (hscs) to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma (mm).

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 100 iu/ml equivalent to 3.6378mg/ml - solution for injection - 100 iu/ml - active: insulin glargine 100 iu/ml equivalent to 3.6378mg/ml excipient: glycerol hydrochloric acid metacresol polysorbate 20 sodium hydroxide water for injection zinc chloride - optisulin/optisulin solostar is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 100 iu/ml equivalent to 3.6378mg/ml - solution for injection - 100 iu/ml - active: insulin glargine 100 iu/ml equivalent to 3.6378mg/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc chloride - optisulin/optisulin solostar is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adenosine 3 mg/ml (candida utilis lysed to get rna,then hydrolysed to adenosine);   - solution for injection - 6 mg/2ml - active: adenosine 3 mg/ml (candida utilis lysed to get rna,then hydrolysed to adenosine)   excipient: sodium chloride water for injection - adenocor is indicated for rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white syndrome), and as an aid to diagnosis of broad or narrow qrs complex supraventricular tachycardias, and in sensitisation of intracavity electrophysiological investigations.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glulisine 3.49 mg/ml - solution for injection - 100 iu/ml - active: insulin glulisine 3.49 mg/ml excipient: cresol hydrochloric acid polysorbate 20 sodium chloride sodium hydroxide trometamol water for injection - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glulisine 3.49 mg/ml - solution for injection - 100 iu/ml - active: insulin glulisine 3.49 mg/ml excipient: hydrochloric acid metacresol polysorbate 20 sodium chloride sodium hydroxide trometamol water for injection - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - leflunomide 10mg - film coated tablet - 10 mg - active: leflunomide 10mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease